Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 729 evidences · page 57 / 70

5 %The prevalence of HIV sero-discordance among in-union HIV patients receiving care in a private health facility in Jos, north central Nigeria, was 5.0%.

NigeriaVIH/sidapublié 2022West African journal of medicinePubMeddocument de 16 observations

2,74 odds_ratioHIV seroprevalence increased with an odds ratio of 2.74 (95% CI, 1.10–7.11; P = .02) compared with historical trends.

NigeriaVIH/sidapublié 2022JAMA network openPubMeddocument de 7 observations

2,35 aHRHIV co-infection significantly increased probability of mortality among DR-TB patients, with an adjusted hazard ratio (aHR) of 2.35.

NigeriaDrug-Resistant tuberculosis (DR-TB) · VIH/sidapublié 2019PloS onePubMeddocument de 10 observations

95 %Among 2,958 persons identified as HIV-positive using the national testing algorithm in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018, 2,800 (95%) were confirmed HIV-positive by supplemental Geenius HIV-1/2 testing.

NigeriaVIH/sidaobservé 2018publié 2022PLOS global public healtheurope_pmcdocument de 10 observations

3,5 %The prevalence of hepatitis B surface antigenemia among HIV positive patients on anti-retroviral treatment programme in Anyigba, Kogi State, North-Central Nigeria was 3.5%.

Nigeriahépatite B · VIH/sidapublié 2019African health sciencesPubMed

85 %85% of the 903 entries (n = 769) were eligible and scored for feasibility, impact, and desirability.

NigeriaVIH/sidaobservé October 2018 to June 2019publié 2020PloS onePubMeddocument de 10 observations

45,4 %Among 262 health care workers in a tertiary health facility in Kano, Nigeria, 45.4% (n=119) listed human milk substitutes as an appropriate feeding choice for HIV-exposed infants.

NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 7 observations

49,97 kgThe mean weight of age-matched HIV-negative controls was 49.97 ± 13.58 kg.

NigeriaVIH/sidapublié 2022BMC pediatricsPubMeddocument de 6 observations

77,1 %Viral suppression at <1000 copies/mL at 12 months was 77.1% (158/205) for point-of-care monitoring and 65.9% (137/208) for standard-of-care monitoring in per-protocol analysis.

NigeriaVIH/sidaobservé 12 monthspublié 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 5 observations

50 %About 50% of individuals needing HIV treatment in Nigeria are unable to access required services.

NigeriaVIH/sidapublié 2022Global health, science and practicePubMeddocument de 4 observations

30 %HIV testing uptake among undergraduate students in Imo State, Nigeria, was 30% at Federal Polytechnic Nekede (FEP) in the past year.

NigeriaVIH/sidapublié 2026Scientific reportsPubMeddocument de 5 observations

Use of antiretroviral therapy among HIV-infected children is associated with a higher health-related quality of life (QoL) in the general health rating, physical resilience, functional score, symptom, social and role functioning domains.

NigeriaVIH/sidapublié 2020West African journal of medicinePubMeddocument de 8 observations

5 casesFive (5.5%) participants were positive for HIV 1 & 2.

NigeriaVIH/sidapublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 8 observations

95,6 %Among 91 HIV-1 infected individuals in Abakaliki metropolis, Ebonyi State, Nigeria, 87 (95.6%) were positive for Epstein-Barr Nuclear Antigen (EBNA) IgG antibody.

NigeriaVIH/sida · virus Epstein-Barrpublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

Nigeria ranked third in the world by number of people living with HIV/AIDS in 2019.

NigeriaVIH/sidaobservé 2019publié 2020African journal of AIDS research : AJARPubMeddocument de 3 observations

14,7 %Adolescents and young adults (AYA) who engaged in transactional sex had higher facility-based HIV testing uptake by an unadjusted risk difference of 14.7%, compared to AYA who never engaged in transactional sex.

NigeriaVIH/sidapublié 2026AIDS (London, England)PubMeddocument de 7 observations

36,2 %The middle-aged population (40–59 years) constituted 36.2% of HIV/AIDS admissions.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations

36,3 %In a study of 146 HIV-infected children in Calabar, Nigeria, conducted from February 1 to September 30, 2015, the prevalence of renal disease was 36.3%.

Nigeriarenal disease · VIH/sidaobservé February 1 to September 30, 2015publié 2022Saudi journal of kidney diseases and transplantation : an official publication of the SaudPubMeddocument de 5 observations

46,8 %46.8% of community pharmacists cited lack of clinical tools as a barrier to integrating HIV/AIDS services into practice.

NigeriaVIH/sidaobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 11 observations

4,8 %HIV prevalence was 4.8% in adults aged 15 years and older in the Akwa Ibom AIDS Indicator Survey.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations

20 copies/mLAmong PLHIV at FMC Katsina, the median viral load was 20 (interquartile range: 20–40) copies/mL in virally suppressed patients.

NigeriaVIH/sidaobservé 2009–2019publié 2021BMC infectious diseasesPubMeddocument de 5 observations

73 %At baseline, 73% of respondents at Akwakuma Girls Secondary School had poor knowledge of HIV/AIDS mode of transmission and prevention.

NigeriaVIH/sidapublié 2024BMC public healthPubMeddocument de 5 observations

22,98 scoreThe mean total score of community pharmacists' involvement in antiretroviral (ARV) medication therapy management (MTM) was 22.98 ± 19.61, with a range of 9–45 and midpoint 27.

NigeriaVIH/sidaobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 11 observations

0,018 AORMothers initiating ART before pregnancy had lower odds of an HIV-positive child after 18 months compared to those who initiated ART after birth (adjusted odds ratio 0.018).

NigeriaVIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 10 observations

28 %Among people living with HIV in Osun State, Nigeria, the prevalence of hyperglycaemia was 28%.

Nigeriahyperglycaemia · VIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 9 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.